Well I have been looking at this company and wow some interesting stuff came up. Their last quarter revenue was $35K. Now that is pretty damn low but at least they have a decent cash horde ($37mill) built up without much debt ($1.87mill.)
I guess this is typical of a company right at the start of a new technology. Lots of companies seemed that way during the dot-com boom. STEM has an outrageously high market cap ($248 mill) for so little of anything in terms of fundamentals.
There seem to be lots of hope built up into this stock but not many results so far. (In fact revenue decreased year to year.) It is pretty much a bet that stem cell research will be the next biotech goldmine. Let's hope the feds will open up the money spiggots and keep this guy flush with the cash to keep their burn rate under control.
No comments:
Post a Comment